Fingerprint
Dive into the research topics of 'Surrogate endpoints in oncology: When are they acceptable for regulatory and clinical decisions, and are they currently overused?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Surrogate endpoints in oncology: When are they acceptable for regulatory and clinical decisions, and are they currently overused?
Robert Kemp, Vinay Prasad
Research output: Contribution to journal › Article › peer-review
162
Scopus
citations